Therefore, this study assessed the roles of stromal barriers in regulating CAR-T cell delivery to cancer cells and the potential of RLN2 expression and secretion by CAR-T cells for enhancing antitumor efficacy in pancreatic and biliary tract cancers. This evidence concerns the gene RLN2 and biliary tract cancer.